Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov;106(5):1133-1140.
doi: 10.1002/cpt.1555. Epub 2019 Jul 23.

Racial/Ethnic-Specific Differences in the Effects of Inhaled Corticosteroid Use on Bronchodilator Response in Patients With Asthma

Affiliations

Racial/Ethnic-Specific Differences in the Effects of Inhaled Corticosteroid Use on Bronchodilator Response in Patients With Asthma

Lesly-Anne Samedy-Bates et al. Clin Pharmacol Ther. 2019 Nov.

Abstract

American Thoracic Society guidelines recommend inhaled corticosteroid (ICS) therapy, plus a short-acting bronchodilator, in patients with persistent asthma. However, few prior studies have examined the efficacy of this combination in children of all racial/ethnic groups. We evaluated the association between ICS use and bronchodilator response (BDR) in three pediatric populations with persistent asthma (656 African American, 916 Puerto Rican, and 398 Mexican American children). The association was assessed using multivariable quantile regression. After adjusting for baseline forced expiratory volume in one second and use of controller medications, ICS use was significantly associated with increased BDR only among Mexican Americans (1.56%, P = 0.028) but not African Americans (0.49%, P = 0.426) or Puerto Ricans (0.16%, P = 0.813). Our results demonstrate that ICS augmentation is disproportionate across racial/ethnic groups, where improved BDR is observed in Mexican Americans only. This study highlights the complexities of treating asthma in children, and reinforces the importance of investigating the influence of race/ethnicity on pharmacological response.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest:

The authors declared no competing interests for this work.

Similar articles

Cited by

References

    1. Eder W, Ege MJ & von Mutius E The asthma epidemic. N Engl J Med 355, 2226–2235 (2006). DOI: 10.1056/NEJMra054308. - DOI - PubMed
    1. World Health Organization. Asthma <http://www.who.int/mediacentre/factsheets/fs307/en/> (2017). Accessed July 24 2018.
    1. Akinbami LJ et al. Trends in asthma prevalence, health care use, and mortality in the United States, 2001–2010. NCHS Data Brief, 1–8 (2012). - PubMed
    1. Moorman JE et al. National surveillance of asthma: United States, 2001–2010. Vital Health Stat 3, 1–58 (2012). - PubMed
    1. Barr RG et al. Pulmonary Disease and Age at Immigration among Hispanics. Results from the Hispanic Community Health Study/Study of Latinos. Am J Respir Crit Care Med 193, 386–395 (2016). DOI: 10.1164/rccm.201506-1211OC. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances